NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells

The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human cancers, has been demonstrated to be a major modulator of angiogenesis. Thus, inhibition of VEGF signaling has the potential for tumor anti-a...

Full description

Saved in:
Bibliographic Details
Published inOncology reports Vol. 35; no. 6; pp. 3630 - 3638
Main Authors XU, ZIHAN, SUN, YAOWEN, GUO, YADONG, QIN, GAOPING, MU, SHENGZHI, FAN, RONGHUI, WANG, BENFENG, GAO, WENJIE, WU, HANGLI, WANG, GUODONG, ZHANG, ZHENXIN
Format Journal Article
LanguageEnglish
Published Greece D.A. Spandidos 01.06.2016
Spandidos Publications
Spandidos Publications UK Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human cancers, has been demonstrated to be a major modulator of angiogenesis. Thus, inhibition of VEGF signaling has the potential for tumor anti-angiogenic therapy. Signal transducer and activator of transcription-3 (STAT3) is a key regulator for angiogenesis by directly binding to the VEGF promoter to upregulate its transcription. Several factors can enhance STAT3 activity to affect angiogenesis. Here, we found that overexpression of nuclear transcription factor-Y alpha (NF-YA) gene could promote cell invasion and angiogenesis accompanying the increase of STAT3 signaling in human melanoma cells. Moreover, the expression and secretion of VEGF was also found to be upregulated by the overexpression of NF-YA gene in melanoma cells. The STAT3 inhibitor was able to attenuate the upregulation of VEGF induced by NF-YA overexpression. Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of the Polycomb repressive complex 2, enhances STAT3 activity by mediating its lysine methylation. We also showed that NF-YA upregulated the expression of EZH2 and NF-YA-induced angiogenesis could be inhibited by EZH2 knockdown. Taken together, these findings indicate that overexpression of NF-YA contributes to tumor angiogenesis through EZH2-STAT3 signaling in human melanoma cells, highlighting NF-YA as a potential therapeutic target in human melanoma.
AbstractList The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human cancers, has been demonstrated to be a major modulator of angiogenesis. Thus, inhibition of VEGF signaling has the potential for tumor anti-angiogenic therapy. Signal transducer and activator of transcription-3 (STAT3) is a key regulator for angiogenesis by directly binding to the VEGF promoter to upregulate its transcription. Several factors can enhance STAT3 activity to affect angiogenesis. Here, we found that overexpression of nuclear transcription factor-Y alpha (NF-YA) gene could promote cell invasion and angiogenesis accompanying the increase of STAT3 signaling in human melanoma cells. Moreover, the expression and secretion of VEGF was also found to be upregulated by the overexpression of NF-YA gene in melanoma cells. The STAT3 inhibitor was able to attenuate the upregulation of VEGF induced by NF-YA overexpression. Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of the Polycomb repressive complex 2, enhances STAT3 activity by mediating its lysine methylation. We also showed that NF-YA upregulated the expression of EZH2 and NF-YA‑induced angiogenesis could be inhibited by EZH2 knockdown. Taken together, these findings indicate that overexpression of NF-YA contributes to tumor angiogenesis through EZH2-STAT3 signaling in human melanoma cells, highlighting NF-YA as a potential therapeutic target in human melanoma.
The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human cancers, has been demonstrated to be a major modulator of angiogenesis. Thus, inhibition of VEGF signaling has the potential for tumor anti-angiogenic therapy. Signal transducer and activator of transcription-3 (STAT3) is a key regulator for angiogenesis by directly binding to the VEGF promoter to upregulate its transcription. Several factors can enhance STAT3 activity to affect angiogenesis. Here, we found that overexpression of nuclear transcription factor-Y alpha (NF-YA) gene could promote cell invasion and angiogenesis accompanying the increase of STAT3 signaling in human melanoma cells. Moreover, the expression and secretion of VEGF was also found to be upregulated by the overexpression of NF-YA gene in melanoma cells. The STAT3 inhibitor was able to attenuate the upregulation of VEGF induced by NF-YA overexpression. Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of the Polycomb repressive complex 2, enhances STAT3 activity by mediating its lysine methylation. We also showed that NF-YA upregulated the expression of EZH2 and NF-YA-induced angiogenesis could be inhibited by EZH2 knockdown. Taken together, these findings indicate that overexpression of NF-YA contributes to tumor angiogenesis through EZH2-STAT3 signaling in human melanoma cells, highlighting NF-YA as a potential therapeutic target in human melanoma.
Audience Academic
Author WANG, BENFENG
QIN, GAOPING
ZHANG, ZHENXIN
MU, SHENGZHI
FAN, RONGHUI
XU, ZIHAN
WANG, GUODONG
SUN, YAOWEN
GAO, WENJIE
GUO, YADONG
WU, HANGLI
Author_xml – sequence: 1
  givenname: ZIHAN
  surname: XU
  fullname: XU, ZIHAN
– sequence: 2
  givenname: YAOWEN
  surname: SUN
  fullname: SUN, YAOWEN
– sequence: 3
  givenname: YADONG
  surname: GUO
  fullname: GUO, YADONG
– sequence: 4
  givenname: GAOPING
  surname: QIN
  fullname: QIN, GAOPING
– sequence: 5
  givenname: SHENGZHI
  surname: MU
  fullname: MU, SHENGZHI
– sequence: 6
  givenname: RONGHUI
  surname: FAN
  fullname: FAN, RONGHUI
– sequence: 7
  givenname: BENFENG
  surname: WANG
  fullname: WANG, BENFENG
– sequence: 8
  givenname: WENJIE
  surname: GAO
  fullname: GAO, WENJIE
– sequence: 9
  givenname: HANGLI
  surname: WU
  fullname: WU, HANGLI
– sequence: 10
  givenname: GUODONG
  surname: WANG
  fullname: WANG, GUODONG
– sequence: 11
  givenname: ZHENXIN
  surname: ZHANG
  fullname: ZHANG, ZHENXIN
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27109360$$D View this record in MEDLINE/PubMed
BookMark eNptkcFrFDEUxoNUbLt68ywDgngwa5I3k8kcl9JaoejBFdRLyM68zKbMJGsyI_S_N0Nra0VCSHj8vvfy5TslRz54JOQlZ2tQjXgf4lowLtdlLfkTcsLrhlNRAj_KdyY4Bai-HZPTlK4ZEzWTzTNyLGrOGpDshOCnC_p9UxxiGMOEqXD-l0ku-ML4Lu_ehR49JpeK3U0xHyL282Am5_vi_MeloF-2my0UyfXeDEvR-WI_j8YXIw7Gh9EULQ5Dek6eWjMkfHF3rsjXi_Pt2SW9-vzh49nmiralkhNtrNwprmol0aI1rFFKIC93YFVdYtMBb0XJS9ZZpmRVQdW1OyUBre1a2QLAiry97Zv9_JwxTXp0aXmB8RjmpHmt6gZqyNoVef0Peh3mmG1kqgEhFYDgD1RvBtTO2zBF0y5N9aasqlI1rFyo9X-ovDocXZvjsi7XHwne_CXYoxmmfQrDPOWfT4_Bd7dgG0NKEa0-RDeaeKM500v8OkS9xK-X-DP-6s7UvBuxu4f_5P0wOB1ywK4L6Z4JkUJFmaQggcFvDwW1hg
CitedBy_id crossref_primary_10_1038_s41419_018_0291_9
crossref_primary_10_1002_jcp_28564
crossref_primary_10_1186_s13148_020_00862_0
crossref_primary_10_1111_jcmm_14579
crossref_primary_10_1002_path_5987
crossref_primary_10_1016_j_bbcan_2024_189082
crossref_primary_10_1016_j_prp_2018_08_005
crossref_primary_10_1111_jcmm_15777
crossref_primary_10_3892_ijo_2019_4880
crossref_primary_10_3390_biomedicines8120637
crossref_primary_10_18632_oncotarget_12928
crossref_primary_10_1016_j_bcp_2023_115594
crossref_primary_10_2217_epi_2020_0186
crossref_primary_10_1016_j_yexcr_2018_10_007
crossref_primary_10_1016_j_neurobiolaging_2018_04_019
crossref_primary_10_18632_oncotarget_19932
crossref_primary_10_1096_fj_201801989R
crossref_primary_10_1038_s41598_021_90081_1
Cites_doi 10.1016/j.ccr.2013.04.008
10.1038/sj.onc.1205260
10.1182/blood-2010-03-273441
10.1038/ncomms5255
10.3892/or.2014.3114
10.1046/j.1087-0024.2000.00003.x
10.1161/01.RES.0000259593.07661.1e
10.1242/jcs.125021
10.1038/srep00650
10.2147/vhrm.2006.2.3.213
10.1038/ni.3125
10.1172/JCI70626
10.1038/sj.onc.1206226
10.1200/JCO.2014.60.0759
10.1158/1541-7786.MCR-12-0661
10.1038/cddis.2013.527
10.1016/j.molcel.2012.09.004
10.1371/journal.pone.0095993
10.1053/j.seminoncol.2007.09.009
10.1172/JCI70212
10.1038/nrm909
10.4049/jimmunol.1302943
10.1186/1479-5876-6-53
10.1016/j.cellsig.2013.05.007
10.1038/nrc2403
10.3892/or.2014.2974
10.1038/srep08229
10.1200/JCO.2012.47.3728
10.1038/nm.2575
10.18632/oncotarget.3257
10.1023/A:1010094431748
10.1155/2012/647684
10.1007/978-1-61779-980-8_23
10.1177/1947601911423031
10.1182/blood.V95.1.189
10.1038/nrc1886
10.1038/sj.onc.1204390
ContentType Journal Article
Copyright Copyright © 2016, Spandidos Publications
COPYRIGHT 2016 Spandidos Publications
Copyright Spandidos Publications UK Ltd. 2016
Copyright_xml – notice: Copyright © 2016, Spandidos Publications
– notice: COPYRIGHT 2016 Spandidos Publications
– notice: Copyright Spandidos Publications UK Ltd. 2016
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.3892/or.2016.4761
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
British Nursing Database
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
British Nursing Index with Full Text
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

ProQuest One Academic Eastern Edition
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: ProQuest_Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1791-2431
EndPage 3638
ExternalDocumentID A455489041
10_3892_or_2016_4761
27109360
or-35-06-3630
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID -
0R
123
2WC
3V.
53G
7X7
88E
8FI
8FJ
AAPBV
AASXA
ABPMR
ABUWG
ACGFS
ADBBV
AENEX
AFKRA
AGCAB
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AN0
BAWUL
BBAFP
BENPR
BNQBC
BPHCQ
BVXVI
C45
CS3
DIK
E3Z
EBD
EBS
EJD
F5P
FRP
FYUFA
GX1
H13
HUR
HZ
IAO
IHR
IHW
INH
INR
ITC
LI0
M1P
O9-
OGEVE
OK1
OVD
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
RIG
SV3
UDS
W2D
---
0R~
ABJNI
AEGXH
AFOSN
ALIPV
CCPQU
CGR
CUY
CVF
ECM
EIF
EMOBN
HMCUK
HZ~
IPNFZ
NPM
ODZKP
TEORI
TR2
UKHRP
AAYXX
CITATION
7XB
8FK
K9.
7X8
ID FETCH-LOGICAL-c486t-9f6b818786efefa09882e14b3f874e9d31c24140df0865535dcb863effdc6c333
IEDL.DBID BENPR
ISSN 1021-335X
IngestDate Tue Aug 27 04:39:21 EDT 2024
Thu Oct 10 14:23:28 EDT 2024
Thu Feb 22 23:57:02 EST 2024
Tue Nov 12 23:25:26 EST 2024
Tue Aug 20 22:07:37 EDT 2024
Fri Aug 23 00:41:27 EDT 2024
Tue Aug 27 13:47:06 EDT 2024
Tue Jan 05 23:28:26 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c486t-9f6b818786efefa09882e14b3f874e9d31c24140df0865535dcb863effdc6c333
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.spandidos-publications.com/10.3892/or.2016.4761/download
PMID 27109360
PQID 1932683321
PQPubID 2044953
PageCount 9
ParticipantIDs proquest_miscellaneous_1787937355
proquest_journals_1932683321
gale_infotracmisc_A455489041
gale_infotracacademiconefile_A455489041
gale_healthsolutions_A455489041
crossref_primary_10_3892_or_2016_4761
pubmed_primary_27109360
spandidos_primary_or-35-06-3630
PublicationCentury 2000
PublicationDate 2016-06-01
PublicationDateYYYYMMDD 2016-06-01
PublicationDate_xml – month: 06
  year: 2016
  text: 2016-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Athens
PublicationTitle Oncology reports
PublicationTitleAlternate Oncol Rep
PublicationYear 2016
Publisher D.A. Spandidos
Spandidos Publications
Spandidos Publications UK Ltd
Publisher_xml – name: D.A. Spandidos
– name: Spandidos Publications
– name: Spandidos Publications UK Ltd
References Orgaz, Pandya, Dalmeida, Karagiannis, Sanchez-Laorden, Viros, Albrengues, Nestle, Ridley, Gaggioli (b29-or-35-06-3630) 2014; 5
Mehlen, Puisieux (b3-or-35-06-3630) 2006; 6
Zhuang (b15-or-35-06-3630) 2013; 25
Lee, Lee, Kim, Kim, Park, Kim, Lee, Kim, Kim, Lee (b20-or-35-06-3630) 2012; 48
Wei, Kuo, Chen, Chou, Lai, Lee, Hsieh (b12-or-35-06-3630) 2003; 22
Zhang, Li, Cornelia, Swisher, Kim (b11-or-35-06-3630) 2012; 2
Nishida, Yano, Nishida, Kamura, Kojiro (b35-or-35-06-3630) 2006; 2
Ellis, Hicklin (b6-or-35-06-3630) 2008; 8
Mora, Buettner, Seigne, Diaz, Ahmad, Garcia, Bowman, Falcone, Fairclough, Cantor (b16-or-35-06-3630) 2002; 62
Schaafhausen, Yang, Centanin, Wittbrodt, Bosserhoff, Fischer, Schartl, Meierjohann (b5-or-35-06-3630) 2013; 126
Yeh, Kim (b9-or-35-06-3630) 2015; 33
Judd, Menheniott, Ling, Jackson, Howlett, Kalantzis, Priebe, Giraud (b32-or-35-06-3630) 2014; 9
Niu, Wright, Huang, Song, Haura, Turkson, Zhang, Wang, Sinibaldi, Coppola (b17-or-35-06-3630) 2002; 21
Tas (b1-or-35-06-3630) 2012; 2012
Caganova, Carrisi, Varano, Mainoldi, Zanardi, Germain, George, Alberghini, Ferrarini, Talukder (b19-or-35-06-3630) 2013; 123
Welti, Loges, Dimmeler, Carmeliet (b7-or-35-06-3630) 2013; 123
Lamalice, Le Boeuf, Huot (b4-or-35-06-3630) 2007; 100
Zhou, Ren, Liu, Han, Zhang, Li, Li, Li, Kang, Wang (b33-or-35-06-3630) 2014; 31
Shibuya (b38-or-35-06-3630) 2011; 2
Kim, Kim, Woo, Shin, Shin, Chang, Oh, Kim, Rheey, Nakano (b23-or-35-06-3630) 2013; 23
Eustace, Crown, Clynes, O'Donovan (b30-or-35-06-3630) 2008; 6
Kimura, Weisz, Kurashima, Hashimoto, Ogura, D'Acquisto, Addeo, Makuuchi, Esumi (b13-or-35-06-3630) 2000; 95
Jia, Hong, Lei, Li, Li, Mo, Wang, Shao, Shen, Cheng (b8-or-35-06-3630) 2015; 6
Levy, Darnell (b14-or-35-06-3630) 2002; 3
Geller, Clapp, Sober, Gonsalves, Mueller, Christiansen, Shaikh, Miller (b2-or-35-06-3630) 2013; 31
Domashenko, Wiener, Emerson (b24-or-35-06-3630) 2012; 916
Cao, Zhou, Zhao, Jin, Yu, Yan, Hu, Guo (b10-or-35-06-3630) 2014; 31
Detmar (b39-or-35-06-3630) 2000; 5
Rao, Dhele, Cheemadan, Ketkar, Jayandharan, Palakodeti, Rampalli (b18-or-35-06-3630) 2015; 5
Jin, Fan, Fan, Zhao, Tong, Blanck, Alomo, Rajasekaran, Zhan (b27-or-35-06-3630) 2001; 20
Matuoka, Chen (b28-or-35-06-3630) 2000; 1
Garipov, Li, Bitler, Thapa, Balachandran, Zhang (b34-or-35-06-3630) 2013; 11
Gunawan, Venkatesan, Loh, Wong, Berger, Neo, Li, La Win, Yau, Guo (b21-or-35-06-3630) 2015; 16
Herraiz, Calvo, Pandya, Cantelli, Rodriguez-Hernandez, Orgaz, Kang, Chu, Sahai, Sanz-Moreno (b31-or-35-06-3630) 2015; 108
Domashenko, Danet-Desnoyers, Aron, Carroll, Emerson (b26-or-35-06-3630) 2010; 116
Xue, Lim, Yang, Wang, Jensen, Hedlund, Andersson, Sasahara, Larsson, Galter (b36-or-35-06-3630) 2011; 18
Lin, Chen, Lin, Wang, Chou, Chen (b25-or-35-06-3630) 2014; 5
Tong, He, Xie, Mochizuki, Liu, Mochizuki, Meng, Sun, Zhang, Guo (b22-or-35-06-3630) 2014; 192
Mahabeleshwar, Byzova (b37-or-35-06-3630) 2007; 34
Caganova (key20180107211635_b19-or-35-06-3630) 2013; 123
Mehlen (key20180107211635_b3-or-35-06-3630) 2006; 6
Xue (key20180107211635_b36-or-35-06-3630) 2011; 18
Geller (key20180107211635_b2-or-35-06-3630) 2013; 31
Schaafhausen (key20180107211635_b5-or-35-06-3630) 2013; 126
Levy (key20180107211635_b14-or-35-06-3630) 2002; 3
Herraiz (key20180107211635_b31-or-35-06-3630) 2015; 108
Lamalice (key20180107211635_b4-or-35-06-3630) 2007; 100
Ellis (key20180107211635_b6-or-35-06-3630) 2008; 8
Judd (key20180107211635_b32-or-35-06-3630) 2014; 9
Tas (key20180107211635_b1-or-35-06-3630) 2012; 2012
Zhuang (key20180107211635_b15-or-35-06-3630) 2013; 25
Kim (key20180107211635_b23-or-35-06-3630) 2013; 23
Domashenko (key20180107211635_b26-or-35-06-3630) 2010; 116
Eustace (key20180107211635_b30-or-35-06-3630) 2008; 6
Shibuya (key20180107211635_b38-or-35-06-3630) 2011; 2
Garipov (key20180107211635_b34-or-35-06-3630) 2013; 11
Niu (key20180107211635_b17-or-35-06-3630) 2002; 21
Jia (key20180107211635_b8-or-35-06-3630) 2015; 6
Orgaz (key20180107211635_b29-or-35-06-3630) 2014; 5
Mahabeleshwar (key20180107211635_b37-or-35-06-3630) 2007; 34
Nishida (key20180107211635_b35-or-35-06-3630) 2006; 2
Lee (key20180107211635_b20-or-35-06-3630) 2012; 48
Jin (key20180107211635_b27-or-35-06-3630) 2001; 20
Rao (key20180107211635_b18-or-35-06-3630) 2015; 5
Detmar (key20180107211635_b39-or-35-06-3630) 2000; 5
Yeh (key20180107211635_b9-or-35-06-3630) 2015; 33
Domashenko (key20180107211635_b24-or-35-06-3630) 2012; 916
Wei (key20180107211635_b12-or-35-06-3630) 2003; 22
Welti (key20180107211635_b7-or-35-06-3630) 2013; 123
Mora (key20180107211635_b16-or-35-06-3630) 2002; 62
Tong (key20180107211635_b22-or-35-06-3630) 2014; 192
Lin (key20180107211635_b25-or-35-06-3630) 2014; 5
Cao (key20180107211635_b10-or-35-06-3630) 2014; 31
Zhang (key20180107211635_b11-or-35-06-3630) 2012; 2
Kimura (key20180107211635_b13-or-35-06-3630) 2000; 95
Matuoka (key20180107211635_b28-or-35-06-3630) 2000; 1
Zhou (key20180107211635_b33-or-35-06-3630) 2014; 31
Gunawan (key20180107211635_b21-or-35-06-3630) 2015; 16
References_xml – volume: 31
  start-page: 417
  year: 2013
  end-page: 4178
  ident: b2-or-35-06-3630
  article-title: Melanoma epidemic: An analysis of six decades of data from the Connecticut Tumor Registry
  publication-title: J Clin Oncol
  contributor:
    fullname: Miller
– volume: 916
  start-page: 303
  year: 2012
  end-page: 316
  ident: b24-or-35-06-3630
  article-title: NF-Ya protein delivery as a tool for hematopoietic progenitor cell expansion
  publication-title: Methods Mol Biol
  contributor:
    fullname: Emerson
– volume: 18
  start-page: 100
  year: 2011
  end-page: 110
  ident: b36-or-35-06-3630
  article-title: PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells
  publication-title: Nat Med
  contributor:
    fullname: Galter
– volume: 123
  start-page: 5009
  year: 2013
  end-page: 5022
  ident: b19-or-35-06-3630
  article-title: Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
  publication-title: J Clin Invest
  contributor:
    fullname: Talukder
– volume: 5
  start-page: 20
  year: 2000
  end-page: 23
  ident: b39-or-35-06-3630
  article-title: Tumor angiogenesis
  publication-title: J Investig Dermatol Symp Proc
  contributor:
    fullname: Detmar
– volume: 6
  start-page: 449
  year: 2006
  end-page: 458
  ident: b3-or-35-06-3630
  article-title: Metastasis: A question of life or death
  publication-title: Nat Rev Cancer
  contributor:
    fullname: Puisieux
– volume: 116
  start-page: 2676
  year: 2010
  end-page: 2683
  ident: b26-or-35-06-3630
  article-title: TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells
  publication-title: Blood
  contributor:
    fullname: Emerson
– volume: 2
  start-page: 650
  year: 2012
  ident: b11-or-35-06-3630
  article-title: Regulation of VEGF expression by HIF-1α in the femoral head cartilage following ischemia osteonecrosis
  publication-title: Sci Rep
  contributor:
    fullname: Kim
– volume: 8
  start-page: 579
  year: 2008
  end-page: 591
  ident: b6-or-35-06-3630
  article-title: VEGF-targeted therapy: Mechanisms of anti-tumour activity
  publication-title: Nat Rev Cancer
  contributor:
    fullname: Hicklin
– volume: 95
  start-page: 189
  year: 2000
  end-page: 197
  ident: b13-or-35-06-3630
  article-title: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
  publication-title: Blood
  contributor:
    fullname: Esumi
– volume: 23
  start-page: 839
  year: 2013
  end-page: 852
  ident: b23-or-35-06-3630
  article-title: Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells
  publication-title: Cancer Cell
  contributor:
    fullname: Nakano
– volume: 100
  start-page: 782
  year: 2007
  end-page: 794
  ident: b4-or-35-06-3630
  article-title: Endothelial cell migration during angiogenesis
  publication-title: Circ Res
  contributor:
    fullname: Huot
– volume: 2
  start-page: 1097
  year: 2011
  end-page: 1105
  ident: b38-or-35-06-3630
  article-title: Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and proangiogenic therapies
  publication-title: Genes Cancer
  contributor:
    fullname: Shibuya
– volume: 1
  start-page: 261
  year: 2000
  end-page: 271
  ident: b28-or-35-06-3630
  article-title: Possible role of subunit A of nuclear factor Y (NF-YA) in normal human diploid fibroblasts during senescence
  publication-title: Biogerontology
  contributor:
    fullname: Chen
– volume: 21
  start-page: 2000
  year: 2002
  end-page: 2008
  ident: b17-or-35-06-3630
  article-title: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
  publication-title: Oncogene
  contributor:
    fullname: Coppola
– volume: 11
  start-page: 360
  year: 2013
  end-page: 369
  ident: b34-or-35-06-3630
  article-title: NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells
  publication-title: Mol Cancer Res
  contributor:
    fullname: Zhang
– volume: 108
  year: 2015
  ident: b31-or-35-06-3630
  article-title: Reactivation of p53 by a cytoskeletal sensor to control the balance between DNA damage and tumor dissemination
  publication-title: J Natl Cancer Inst
  contributor:
    fullname: Sanz-Moreno
– volume: 2
  start-page: 213
  year: 2006
  end-page: 219
  ident: b35-or-35-06-3630
  article-title: Angiogenesis in cancer
  publication-title: Vasc Health Risk Manag
  contributor:
    fullname: Kojiro
– volume: 126
  start-page: 3862
  year: 2013
  end-page: 3872
  ident: b5-or-35-06-3630
  article-title: Tumor angiogenesis is caused by single melanoma cells in a manner dependent on reactive oxygen species and NF-κB
  publication-title: J Cell Sci
  contributor:
    fullname: Meierjohann
– volume: 33
  start-page: 1505
  year: 2015
  end-page: 1508
  ident: b9-or-35-06-3630
  article-title: Targeting tumor hypoxia with hypoxia-activated prodrugs
  publication-title: J Clin Oncol
  contributor:
    fullname: Kim
– volume: 5
  start-page: e987
  year: 2014
  ident: b25-or-35-06-3630
  article-title: Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage
  publication-title: Cell Death Dis
  contributor:
    fullname: Chen
– volume: 62
  start-page: 6659
  year: 2002
  end-page: 6666
  ident: b16-or-35-06-3630
  article-title: Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells
  publication-title: Cancer Res
  contributor:
    fullname: Cantor
– volume: 2012
  start-page: 647684
  year: 2012
  ident: b1-or-35-06-3630
  article-title: Metastatic behavior in melanoma: Timing, pattern, survival, and influencing factors
  publication-title: J Oncol
  contributor:
    fullname: Tas
– volume: 34
  start-page: 555
  year: 2007
  end-page: 565
  ident: b37-or-35-06-3630
  article-title: Angiogenesis in melanoma
  publication-title: Semin Oncol
  contributor:
    fullname: Byzova
– volume: 31
  start-page: 1205
  year: 2014
  end-page: 1210
  ident: b10-or-35-06-3630
  article-title: PGC-1α integrates glucose metabolism and angiogenesis in multiple myeloma cells by regulating VEGF and GLUT-4
  publication-title: Oncol Rep
  contributor:
    fullname: Guo
– volume: 5
  start-page: 4255
  year: 2014
  ident: b29-or-35-06-3630
  article-title: Diverse matrix metalloproteinase functions regulate cancer amoeboid migration
  publication-title: Nat Commun
  contributor:
    fullname: Gaggioli
– volume: 123
  start-page: 3190
  year: 2013
  end-page: 3200
  ident: b7-or-35-06-3630
  article-title: Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
  publication-title: J Clin Invest
  contributor:
    fullname: Carmeliet
– volume: 20
  start-page: 2683
  year: 2001
  end-page: 2690
  ident: b27-or-35-06-3630
  article-title: Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage
  publication-title: Oncogene
  contributor:
    fullname: Zhan
– volume: 3
  start-page: 651
  year: 2002
  end-page: 662
  ident: b14-or-35-06-3630
  article-title: Stats: Transcriptional control and biological impact
  publication-title: Nat Rev Mol Cell Biol
  contributor:
    fullname: Darnell
– volume: 48
  start-page: 572
  year: 2012
  end-page: 586
  ident: b20-or-35-06-3630
  article-title: EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex
  publication-title: Mol Cell
  contributor:
    fullname: Lee
– volume: 22
  start-page: 1517
  year: 2003
  end-page: 1527
  ident: b12-or-35-06-3630
  article-title: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
  publication-title: Oncogene
  contributor:
    fullname: Hsieh
– volume: 9
  start-page: e95993
  year: 2014
  ident: b32-or-35-06-3630
  article-title: Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
  publication-title: PLoS One
  contributor:
    fullname: Giraud
– volume: 6
  start-page: 8648
  year: 2015
  end-page: 8662
  ident: b8-or-35-06-3630
  article-title: Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer
  publication-title: Oncotarget
  contributor:
    fullname: Cheng
– volume: 25
  start-page: 1924
  year: 2013
  end-page: 1931
  ident: b15-or-35-06-3630
  article-title: Regulation of STAT signaling by acetylation
  publication-title: Cell Signal
  contributor:
    fullname: Zhuang
– volume: 192
  start-page: 5012
  year: 2014
  end-page: 5022
  ident: b22-or-35-06-3630
  article-title: Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice
  publication-title: J Immunol
  contributor:
    fullname: Guo
– volume: 5
  start-page: 8229
  year: 2015
  ident: b18-or-35-06-3630
  article-title: Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming
  publication-title: Sci Rep
  contributor:
    fullname: Rampalli
– volume: 16
  start-page: 505
  year: 2015
  end-page: 516
  ident: b21-or-35-06-3630
  article-title: The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin
  publication-title: Nat Immunol
  contributor:
    fullname: Guo
– volume: 31
  start-page: 2173
  year: 2014
  end-page: 2180
  ident: b33-or-35-06-3630
  article-title: STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo
  publication-title: Oncol Rep
  contributor:
    fullname: Wang
– volume: 6
  start-page: 53
  year: 2008
  ident: b30-or-35-06-3630
  article-title: Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
  publication-title: J Transl Med
  contributor:
    fullname: O'Donovan
– volume: 23
  start-page: 839
  year: 2013
  ident: key20180107211635_b23-or-35-06-3630
  article-title: Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.04.008
  contributor:
    fullname: Kim
– volume: 21
  start-page: 2000
  year: 2002
  ident: key20180107211635_b17-or-35-06-3630
  article-title: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1205260
  contributor:
    fullname: Niu
– volume: 116
  start-page: 2676
  year: 2010
  ident: key20180107211635_b26-or-35-06-3630
  article-title: TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells
  publication-title: Blood
  doi: 10.1182/blood-2010-03-273441
  contributor:
    fullname: Domashenko
– volume: 62
  start-page: 6659
  year: 2002
  ident: key20180107211635_b16-or-35-06-3630
  article-title: Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells
  publication-title: Cancer Res
  contributor:
    fullname: Mora
– volume: 5
  start-page: 4255
  year: 2014
  ident: key20180107211635_b29-or-35-06-3630
  article-title: Diverse matrix metalloproteinase functions regulate cancer amoeboid migration
  publication-title: Nat Commun
  doi: 10.1038/ncomms5255
  contributor:
    fullname: Orgaz
– volume: 31
  start-page: 2173
  year: 2014
  ident: key20180107211635_b33-or-35-06-3630
  article-title: STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo
  publication-title: Oncol Rep
  doi: 10.3892/or.2014.3114
  contributor:
    fullname: Zhou
– volume: 5
  start-page: 20
  year: 2000
  ident: key20180107211635_b39-or-35-06-3630
  article-title: Tumor angiogenesis
  publication-title: J Investig Dermatol Symp Proc
  doi: 10.1046/j.1087-0024.2000.00003.x
  contributor:
    fullname: Detmar
– volume: 100
  start-page: 782
  year: 2007
  ident: key20180107211635_b4-or-35-06-3630
  article-title: Endothelial cell migration during angiogenesis
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000259593.07661.1e
  contributor:
    fullname: Lamalice
– volume: 126
  start-page: 3862
  year: 2013
  ident: key20180107211635_b5-or-35-06-3630
  article-title: Tumor angiogenesis is caused by single melanoma cells in a manner dependent on reactive oxygen species and NF-κB
  publication-title: J Cell Sci
  doi: 10.1242/jcs.125021
  contributor:
    fullname: Schaafhausen
– volume: 2
  start-page: 650
  year: 2012
  ident: key20180107211635_b11-or-35-06-3630
  article-title: Regulation of VEGF expression by HIF-1α in the femoral head cartilage following ischemia osteonecrosis
  publication-title: Sci Rep
  doi: 10.1038/srep00650
  contributor:
    fullname: Zhang
– volume: 108
  year: 2015
  ident: key20180107211635_b31-or-35-06-3630
  article-title: Reactivation of p53 by a cytoskeletal sensor to control the balance between DNA damage and tumor dissemination
  publication-title: J Natl Cancer Inst
  contributor:
    fullname: Herraiz
– volume: 2
  start-page: 213
  year: 2006
  ident: key20180107211635_b35-or-35-06-3630
  article-title: Angiogenesis in cancer
  publication-title: Vasc Health Risk Manag
  doi: 10.2147/vhrm.2006.2.3.213
  contributor:
    fullname: Nishida
– volume: 16
  start-page: 505
  year: 2015
  ident: key20180107211635_b21-or-35-06-3630
  article-title: The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin
  publication-title: Nat Immunol
  doi: 10.1038/ni.3125
  contributor:
    fullname: Gunawan
– volume: 123
  start-page: 5009
  year: 2013
  ident: key20180107211635_b19-or-35-06-3630
  article-title: Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
  publication-title: J Clin Invest
  doi: 10.1172/JCI70626
  contributor:
    fullname: Caganova
– volume: 22
  start-page: 1517
  year: 2003
  ident: key20180107211635_b12-or-35-06-3630
  article-title: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1206226
  contributor:
    fullname: Wei
– volume: 33
  start-page: 1505
  year: 2015
  ident: key20180107211635_b9-or-35-06-3630
  article-title: Targeting tumor hypoxia with hypoxia-activated prodrugs
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2014.60.0759
  contributor:
    fullname: Yeh
– volume: 11
  start-page: 360
  year: 2013
  ident: key20180107211635_b34-or-35-06-3630
  article-title: NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-12-0661
  contributor:
    fullname: Garipov
– volume: 5
  start-page: e987
  year: 2014
  ident: key20180107211635_b25-or-35-06-3630
  article-title: Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2013.527
  contributor:
    fullname: Lin
– volume: 48
  start-page: 572
  year: 2012
  ident: key20180107211635_b20-or-35-06-3630
  article-title: EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2012.09.004
  contributor:
    fullname: Lee
– volume: 9
  start-page: e95993
  year: 2014
  ident: key20180107211635_b32-or-35-06-3630
  article-title: Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0095993
  contributor:
    fullname: Judd
– volume: 34
  start-page: 555
  year: 2007
  ident: key20180107211635_b37-or-35-06-3630
  article-title: Angiogenesis in melanoma
  publication-title: Semin Oncol
  doi: 10.1053/j.seminoncol.2007.09.009
  contributor:
    fullname: Mahabeleshwar
– volume: 123
  start-page: 3190
  year: 2013
  ident: key20180107211635_b7-or-35-06-3630
  article-title: Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
  publication-title: J Clin Invest
  doi: 10.1172/JCI70212
  contributor:
    fullname: Welti
– volume: 3
  start-page: 651
  year: 2002
  ident: key20180107211635_b14-or-35-06-3630
  article-title: Stats: Transcriptional control and biological impact
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm909
  contributor:
    fullname: Levy
– volume: 192
  start-page: 5012
  year: 2014
  ident: key20180107211635_b22-or-35-06-3630
  article-title: Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1302943
  contributor:
    fullname: Tong
– volume: 6
  start-page: 53
  year: 2008
  ident: key20180107211635_b30-or-35-06-3630
  article-title: Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-6-53
  contributor:
    fullname: Eustace
– volume: 25
  start-page: 1924
  year: 2013
  ident: key20180107211635_b15-or-35-06-3630
  article-title: Regulation of STAT signaling by acetylation
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2013.05.007
  contributor:
    fullname: Zhuang
– volume: 8
  start-page: 579
  year: 2008
  ident: key20180107211635_b6-or-35-06-3630
  article-title: VEGF-targeted therapy: Mechanisms of anti-tumour activity
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2403
  contributor:
    fullname: Ellis
– volume: 31
  start-page: 1205
  year: 2014
  ident: key20180107211635_b10-or-35-06-3630
  article-title: PGC-1α integrates glucose metabolism and angiogenesis in multiple myeloma cells by regulating VEGF and GLUT-4
  publication-title: Oncol Rep
  doi: 10.3892/or.2014.2974
  contributor:
    fullname: Cao
– volume: 5
  start-page: 8229
  year: 2015
  ident: key20180107211635_b18-or-35-06-3630
  article-title: Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming
  publication-title: Sci Rep
  doi: 10.1038/srep08229
  contributor:
    fullname: Rao
– volume: 31
  start-page: 417
  year: 2013
  ident: key20180107211635_b2-or-35-06-3630
  article-title: Melanoma epidemic: An analysis of six decades of data from the Connecticut Tumor Registry
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.47.3728
  contributor:
    fullname: Geller
– volume: 18
  start-page: 100
  year: 2011
  ident: key20180107211635_b36-or-35-06-3630
  article-title: PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells
  publication-title: Nat Med
  doi: 10.1038/nm.2575
  contributor:
    fullname: Xue
– volume: 6
  start-page: 8648
  year: 2015
  ident: key20180107211635_b8-or-35-06-3630
  article-title: Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3257
  contributor:
    fullname: Jia
– volume: 1
  start-page: 261
  year: 2000
  ident: key20180107211635_b28-or-35-06-3630
  article-title: Possible role of subunit A of nuclear factor Y (NF-YA) in normal human diploid fibroblasts during senescence
  publication-title: Biogerontology
  doi: 10.1023/A:1010094431748
  contributor:
    fullname: Matuoka
– volume: 2012
  start-page: 647684
  year: 2012
  ident: key20180107211635_b1-or-35-06-3630
  article-title: Metastatic behavior in melanoma: Timing, pattern, survival, and influencing factors
  publication-title: J Oncol
  doi: 10.1155/2012/647684
  contributor:
    fullname: Tas
– volume: 916
  start-page: 303
  year: 2012
  ident: key20180107211635_b24-or-35-06-3630
  article-title: NF-Ya protein delivery as a tool for hematopoietic progenitor cell expansion
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-61779-980-8_23
  contributor:
    fullname: Domashenko
– volume: 2
  start-page: 1097
  year: 2011
  ident: key20180107211635_b38-or-35-06-3630
  article-title: Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and proangiogenic therapies
  publication-title: Genes Cancer
  doi: 10.1177/1947601911423031
  contributor:
    fullname: Shibuya
– volume: 95
  start-page: 189
  year: 2000
  ident: key20180107211635_b13-or-35-06-3630
  article-title: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
  publication-title: Blood
  doi: 10.1182/blood.V95.1.189
  contributor:
    fullname: Kimura
– volume: 6
  start-page: 449
  year: 2006
  ident: key20180107211635_b3-or-35-06-3630
  article-title: Metastasis: A question of life or death
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1886
  contributor:
    fullname: Mehlen
– volume: 20
  start-page: 2683
  year: 2001
  ident: key20180107211635_b27-or-35-06-3630
  article-title: Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1204390
  contributor:
    fullname: Jin
SSID ssj0027069
Score 2.2828863
Snippet The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human...
SourceID proquest
gale
crossref
pubmed
spandidos
SourceType Aggregation Database
Index Database
Publisher
StartPage 3630
SubjectTerms Angiogenesis
CCAAT-Binding Factor - metabolism
Cell adhesion & migration
Cell Line, Tumor
Cellular signal transduction
Chemotherapy
Cytokines
Development and progression
enhancer of zeste homolog 2
Enhancer of Zeste Homolog 2 Protein - metabolism
Gene expression
Genetic aspects
Health aspects
HEK293 Cells
Human Umbilical Vein Endothelial Cells
Humans
Hypoxia
Melanoma
Melanoma - pathology
Methods
Methylation
Molecular targeted therapy
Neoplasm Invasiveness - pathology
Neovascularization, Pathologic - pathology
nuclear transcription factor-Y alpha
Phosphorylation
Plasmids
Properties
Proteins
Signal Transduction
STAT3
STAT3 Transcription Factor - metabolism
Transcription factors
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - metabolism
Vascular Endothelial Growth Factor A - secretion
Title NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells
URI https://www.ncbi.nlm.nih.gov/pubmed/27109360
https://www.proquest.com/docview/1932683321
https://search.proquest.com/docview/1787937355
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LjtMw0GK7EnBBvCksi5FAnMw6seMkJ1RQqwppKwRdqXCJ_FxVYpOStEj8PTNJmt1y4JCTx0k8nrdnPIS8cdakVlvOTBw7JsG9ZiaKNLgqiVTBGc_bi-fPF2p-IT-vklUfcGv6tMq9TGwFtassxsjPWkMjEyKOPmx-MewahaerfQuNI3Icg6fAR-T443Tx5eu1y8XbpnbYv5oJkay61HdQ0vFZhbeBRuq9TFV0oJT-Fc03dNMd4PLSrV3V3FBCs_vkXm890km33Q_ILV8-JLfP-_PxR8QvZuz7hG7aHDvf0HX5W2M4jML74LlcV5co29YNNX_oblN3jehBe9Hpj3nMvi0nS0ExpUNjlTpMp20PP3rlf-qyutIU4_zNY3Ixmy4_zVnfSIFZmakty4MyoJjTTPngg-Y5mNU-kkaELJU-dyKyoMgld4FjnapIYAczJXwIziorhHhCRmVV-meE2kSbLA9JrgzYIjzV0gSvdMi0j7lL8jF5u8dksenuyyjAz0CMF1VdIMYLxPiYvEI0F12158BmxUSCfZPlXALEuxYCGW1bayCorl4A_gOvrDqAPDmABAaxh8P7rSx6Bm2Ka3Iak9fDMM7EpLPSVzuAAWEG1htYZGPytCOBYU0x5rAKxWEdA00Mg1XNRNImFSrBn___8y_IXURKl312Qkbbeudfgp2zNafkKF2lpz1J_wW0nPqY
link.rule.ids 315,783,787,12068,21400,27936,27937,31731,31732,33756,33757,43322,43817,74073,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw0IJNYrwgvikMZiQQT2ZO7DjJEyqoVYG1QtBJhRfLduypEktK0iLx77lL0m7lgYc8-ZzE5_v2-Y6QV4WzqTOOMxvHBZPgXjMbRQZclUSqUFjP28Lz05manMtPi2TRB9yaPq1yKxNbQV1UDmPkp62hkQkRR-9Wvxh2jcLT1b6Fxk1yiKWqwPk6fD-affl65XLxtqkd9q9mQiSLLvUdlHR8WmE10Ei9lamK9pTSv6L5mm46Ai4vi2VRNdeU0PguudNbj3TYbfc9csOX98mtaX8-_oD42Zh9H9JVm2PnG7osfxsMh1F4HzwXy-oCZduyofYP3azqrhE9aC86-jGJ2bf5cC4opnQYvKUO02nbw49e-p-mrC4NxTh_85Ccj0fzDxPWN1JgTmZqzfKgLCjmNFM--GB4Dma1j6QVIUulzwsROVDkkheB4z1VkcAOZkr4EAqnnBDiETkoq9I_IdQlxmZ5SHJlwRbhqZE2eGVCZnzMiyQfkNdbTOpVVy9Dg5-BGNdVrRHjGjE-ICeIZt3d9tyxmR5KsG-ynEuAeNNCIKOtawME1d0XgP_AklV7kMd7kMAgbn94u5W6Z9BGX5HTgLzcDeNMTDorfbUBGBBmYL2BRTYgjzsS2K0pxhxWoTisY0cTu8GqZiJpkwqV4E____kTcjSZT8_02cfZ52fkNiKoy0Q7JgfreuOfg82zti96wv4L3LX8qw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLegkwYXxDeFwYwE4mTqxI6TnFCBVuVj1QSdVHaJ7NieKrGkJC0S_z3vJWm2cuCQk5-T-Pl92j_7EfLK5ibOdc6ZCUPLJKTXzASBhlQlkspb43hz8fzJXM3O5OdltOzwT3UHq9zZxMZQ2zLHNfJRE2gkQoTByHewiNOP03frXwwrSOFOa1dO4yY5iKUSfEAO3k_mp9-u0i_eFLjDWtZMiGjZwuDBYYejEm8GDdRbGatgz0H9a6av-alboPGFXdmyvuaQpnfJnS6SpON26u-RG664Tw5Pur3yB8TNp-zHmK4bvJ2r6ar4rXFpjML74LlYlRdo51Y1NX_odl21RenBk9HJ-Sxk3xfjhaAI79B4Yh2606aeH710P3VRXmqKa_71Q3I2nSw-zFhXVIHlMlEblnplwEnHiXLeec1TCLFdII3wSSxdakWQg1OX3HqOZ1ZFBLOZKOG8t7nKhRCPyKAoC_eE0DzSJkl9lCoDcQmPtTTeKe0T7UJuo3RIXu84ma3buzMyyDmQ41lZZcjxDDk-JMfI5qw9-dmrXDaWEOskKZdA8aahQKXbVBqEqz07AP-B11ftUR7tUYKy5PvNu6nMOmWtsyvRGpKXfTP2RABa4cot0IBhg0gOorMhedyKQD-mEPGsQnEYRy8TfWNZMRE1AEOQyaf___wxOQSZzr5-mn95Rm4jf1pQ2hEZbKqtew7hz8a86OT6L84rAOg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NF-YA+promotes+invasion+and+angiogenesis+by+upregulating+EZH2-STAT3+signaling+in+human+melanoma+cells&rft.jtitle=Oncology+reports&rft.au=XU%2C+ZIHAN&rft.au=SUN%2C+YAOWEN&rft.au=GUO%2C+YADONG&rft.au=QIN%2C+GAOPING&rft.date=2016-06-01&rft.pub=Spandidos+Publications+UK+Ltd&rft.issn=1021-335X&rft.eissn=1791-2431&rft.volume=35&rft.issue=6&rft.spage=3630&rft.epage=3638&rft_id=info:doi/10.3892%2For.2016.4761&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1021-335X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1021-335X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1021-335X&client=summon